Financhill
Buy
61

MNDR Quote, Financials, Valuation and Earnings

Last price:
$0.31
Seasonality move :
--
Day range:
$0.30 - $0.33
52-week range:
$0.23 - $29.50
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
0.78x
P/B ratio:
2.63x
Volume:
723.5K
Avg. volume:
1.4M
1-year change:
--
Market cap:
$10.9M
Revenue:
$14M
EPS (TTM):
-$0.45

Analysts' Opinion

  • Consensus Rating
    Mobile-health Network Solutions has received a consensus rating of --. The company's average rating is a -- based on 0 Buy ratings, 0 Hold ratings, and 0 Sell ratings.
  • Price Target Upside
    According to analysts' consensus price target of --, Mobile-health Network Solutions has an estimated upside of 2430.44% from its current price of $0.32.
  • Price Target Downside
    According to analysts, the lowest downside price target is -- representing 100% downside risk from its current price of $0.32.

Fair Value

  • According to the consensus of 0 analysts, Mobile-health Network Solutions has 2430.44% upside to fair value with a price target of -- per share.

MNDR vs. S&P 500

  • Over the past 5 trading days, Mobile-health Network Solutions has overperformed the S&P 500 by 9.73% suggesting its relative strength compared to the major market average is strong at this time.

Share Buyback

  • Mobile-health Network Solutions does not have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.

Revenue Growth

  • Mobile-health Network Solutions has grown year-over-year revenues for 0 quarters straight. In the most recent quarter Mobile-health Network Solutions reported revenues of --.

Earnings Growth

  • Mobile-health Network Solutions has grown year-over-year earnings for 0 quarters straight. In the most recent quarter Mobile-health Network Solutions reported earnings per share of --.
Enterprise value:
4.2M
EV / Invested capital:
--
Price / LTM sales:
0.78x
EV / EBIT:
--
EV / Revenue:
0.30x
PEG ratio (5yr expected):
--
EV / Free cash flow:
-1.72x
Price / Operating cash flow:
--
Enterprise value / EBITDA:
--
Gross Profit (TTM):
$2.5M
Return On Assets:
-307.22%
Net Income Margin (TTM):
-111.7%
Return On Equity:
-1223.46%
Return On Invested Capital:
-1223.46%
Operating Margin:
--
Trailing 12 Months Fiscal Quarters
Period Ending 2022-12-29 2023-12-29 2023-12-29
Income Statement
Revenue -- -- -- -- --
Gross Profit -- -- -- -- --
Operating Income -- -- -- -- --
EBITDA -- -- -- -- --
Diluted EPS -- -- -- -- --
Period Ending 2020-06-30 2021-06-30 2022-06-30 2023-06-30 2024-06-30
Balance Sheet
Current Assets -- -- $10.5M $2.7M $7.3M
Total Assets -- -- $10.8M $3.4M $8M
Current Liabilities -- -- $1.3M $2.5M $3.2M
Total Liabilities -- -- $2.3M $3.8M $3.8M
Total Equity -- -- $8.4M -$367.2K $4.1M
Total Debt -- -- -- -- --
Trailing 12 Months Fiscal Quarters
Period Ending 2018-05-31 2019-05-31 2020-05-31 2019-05-31 2020-05-31
Cash Flow Statement
Cash Flow Operations -- -- -- $36.2B $33.4B
Cash From Investing -- -- -- $1.4B $1.5B
Cash From Financing -- -- -- -$355.5M -$1B
Free Cash Flow -- -- -- -- --
MNDR
Sector
Market Cap
$10.9M
$45.9M
Price % of 52-Week High
1.07%
46.95%
Dividend Yield
0%
0%
Shareholder Yield
--
-0.6%
1-Year Price Total Return
--
-32.15%
Beta (5-Year)
--
0.772
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Technicals

8-day SMA
Buy
Level $0.29
200-day SMA
Buy
Level $0.00
Bollinger Bands (100)
Sell
Level 0.33 - 0.75
Chaikin Money Flow
Sell
Level -54.5M
20-day SMA
Buy
Level $0.30
Relative Strength Index (RSI14)
Sell
Level 49.71
ADX Line
Buy
Level 22.52
Williams %R
Neutral
Level -33.9161
50-day SMA
Sell
Level $0.36
MACD (12, 26)
Sell
Level -0.02
25-day Aroon Oscillator
Sell
Level -44
On Balance Volume
Neutral
Level 26.3M

Financial Scores

Sell
Altman Z-Score (Annual)
Level (-0.8404)
Sell
CA Score (Annual)
Level (-12.7035)
--
Beneish M-Score (Annual)
Level (--)
--
Momentum Score
Level (--)
Sell
Ohlson Score
Level (15.3078)
Buy
Piotroski F Score (Annual)
Level (5)
--
Quality Ratio Score
Level (--)
--
Fundamental Score
Level (--)

Revenue Forecast

Earnings per Share Forecast

Company Profile

Mobile-health Network Solutions is a company engaged in providing telehealth solutions in terms of various matrices, such as the number of patient consultations per day and the ranking of its mobile application. It provides services on its MaNaDr platform, which is accessible via mobile application and website. The MaNaDr platform is a platform designed and created by doctors, for doctors and users, equipped with services like consultations with doctors, e-commerce pharma store, and others. The company's operating segments are Telemedicine and other services which is also its key revenue generating segment, and Sale of medicine and medical devices. Geographically, it derives revenue from Singapore.

Stock Forecast FAQ

In the current month, MNDR has received 0 Buy ratings 0 Hold ratings, and 0 Sell ratings. The MNDR average analyst price target in the past 3 months is --.

  • Where Will Mobile-health Network Solutions Stock Be In 1 Year?

    According to analysts, the consensus estimate is that Mobile-health Network Solutions share price will rise to -- per share over the next 12 months.

  • What Do Analysts Say About Mobile-health Network Solutions?

    Analysts are divided on their view about Mobile-health Network Solutions share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Mobile-health Network Solutions is a Sell and believe this share price will drop from its current level to --.

  • What Is Mobile-health Network Solutions's Price Target?

    The price target for Mobile-health Network Solutions over the next 1-year time period is forecast to be -- according to 0 Wall Street analysts, 0 of them rate the stock a Buy, 0 rate the stock a Sell, and 0 analysts rate the stock a Hold.

  • Is MNDR A Buy, Sell Or Hold?

    According to Wall Street analysts, the consensus rating for Mobile-health Network Solutions is a --. 0 of 0 analysts rate the stock a -- at this time.

  • How Can I Buy Shares Of MNDR?

    You can purchase shares of Mobile-health Network Solutions via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, TastyTrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Mobile-health Network Solutions shares.

  • What Is The Mobile-health Network Solutions Share Price Today?

    Mobile-health Network Solutions was last trading at $0.31 per share. This represents the most recent stock quote for Mobile-health Network Solutions. Yesterday, Mobile-health Network Solutions closed at $0.32 per share.

  • How To Buy Mobile-health Network Solutions Stock Online?

    In order to purchase Mobile-health Network Solutions stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Why Is Coinbase Stock Going Down?
Why Is Coinbase Stock Going Down?

Every way you look at it, Coinbase has had a…

Is Uber Stock a Buy on the Dip?
Is Uber Stock a Buy on the Dip?

Shares of Uber Technologies (NYSE:UBER) have been fading fast in…

Is AMD Stock an All-Time Buy?
Is AMD Stock an All-Time Buy?

Advanced Micro Devices (NASDAQ:AMD) is a high-growth AI stock that…

Stock Ideas

Buy
64
Is AAPL Stock a Buy?

Market Cap: $3.9T
P/E Ratio: 42x

Buy
52
Is NVDA Stock a Buy?

Market Cap: $3.4T
P/E Ratio: 115x

Buy
54
Is MSFT Stock a Buy?

Market Cap: $3.2T
P/E Ratio: 36x

Alerts

Sell
50
LMND alert for Dec 28

Lemonade [LMND] is down 10.69% over the past day.

Sell
50
TSLL alert for Dec 28

Direxion Daily TSLA Bull 2X Shares [TSLL] is down 9.92% over the past day.

Buy
63
SMLR alert for Dec 28

Semler Scientific [SMLR] is down 9.65% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock